Business Context and Reporting Period
Hyliion Holdings Corp. filed a Form 8-K under Item 5.02 regarding the appointment of Dennis M. Gallagher as Chief Operating Officer. The employment agreement was entered into on August 10, 2021, became effective August 16, 2021, and has an initial three-year term ending August 16, 2024. The report was signed on August 16, 2021.
Financial and Compensation Terms
- Annual base salary: $500,000.
- Target annual cash bonus: 75% of base salary, subject to performance goals established by the compensation committee.
- Sign-on bonus: $100,000, repayable if Mr. Gallagher leaves voluntarily or is terminated for cause within one year of hire.
- Initial equity awards, subject to compensation committee approval: a fully vested award with a grant-date value of $235,324 and an award with a grant-date value of $441,606 vesting over three years. These awards are subject to repayment in specified circumstances during the first two years.
- Eligible annual time-based restricted stock unit awards have a grant-date value of $700,000 each, with a minimum assumed share value of $10 for calculating the award.
- Eligible one-time performance-based award: target of 250,000 performance-based restricted stock units, subject to criteria established by the compensation committee through December 31, 2024.
The filing does not provide company revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics for a reporting period.
Material Changes Versus the Prior Comparable Period
The material event disclosed is the hiring of a new Chief Operating Officer and the related compensation and employment arrangements. The filing does not present comparative financial information or quantify changes in operating performance.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- Employment automatically renews for successive 12-month terms unless either party provides at least 180 days’ notice of non-renewal.
- Specified termination circumstances may require severance equal to 12 months of base salary, accelerated vesting of certain equity awards granted more than one year earlier, extended option exercise periods, and up to 12 months of health-benefit reimbursement.
- Upon death, certain outstanding and unvested equity awards immediately vest, excluding performance-based or similar awards.
- Upon a change in control, the performance-based award may vest based on actual achievement of applicable criteria. Certain time-based awards may vest and settle immediately if not assumed, substituted, or continued by the successor.
- The employment agreement includes confidentiality, non-competition, non-solicitation, and intellectual property obligations tied to specified severance benefits.
- Mr. Gallagher also entered into the company’s standard indemnification agreement.
Investor Verification Points
- Verify the final employment agreement and related equity award documents when filed with the company’s Form 10-Q for the quarter ended September 30, 2021.
- Confirm compensation committee approval, actual grant dates, share counts, vesting schedules, and performance criteria for the equity awards.
- Assess the potential dilution and compensation expense associated with the equity awards.
- Review any future disclosure regarding termination, severance, change-in-control treatment, or achievement of performance conditions.